在心力衰竭治疗中,用保存的喷射分数治疗费内伦与螺旋
Eiad Habib1,2, Ramzi Ibrahim3, Hoang Nhat Pham4,5
1Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ, USA. eamhb96@hotmail.com.
Cardiovascular drugs and therapy
|November 28, 2025
概括
费内伦和螺旋乳在心力衰竭中表现出类似的有效性和安全性,其中保留了喷射分数 (HFpEF). 费内伦的全因死亡率较低,这表明在HFpEF管理中存在潜在的益处.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 矿物质皮质类受体抗剂 (MRAs) 对于治疗心力衰竭与保留喷射分数 (HFpEF) 至关重要.
- 在HFpEF中,类固醇 (例如,螺旋乳) 和非类固醇 (例如,芬) MRA之间的比较有效性数据有限.
- 了解差异性结果对于优化HFpEF治疗策略至关重要.
研究的目的:
- 在患有HFpEF的患者中,直接比较费内伦与螺旋的心血管和安全结果.
- 在现实世界HFpEF群体中评估类固醇和非类固醇MRA的比较有效性.
主要方法:
- 使用全球联合健康研究网络进行的回顾性队列研究.
- 包括2021年1月至2025年8月期间新发性HFpEF的成年患者.
- 倾向性得分匹配 (1:1) 以平衡基线特征,其次是考克斯比例危险建模以评估结果.
主要成果:
- 芬瑞和螺旋乳组之间的急性心力衰竭事件是相似的 (HR 1.26).
- 与螺旋乳相比,fineerenone队列中所有原因的死亡率明显较低 (HR 0.48).
- 两个MRA组之间主要的不良心血管事件,急性损伤和高胆血症的发生率是可比的.
结论:
- 在HFpEF患者中,芬瑞的有效性和安全性与螺旋乳相似.
- 观察到使用finerenone的较低全因死亡率需要进一步调查.
- 这些发现产生了假设,支持了前性试验的必要性,以确认疗效和安全性.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
869
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
869
01:22Heart Failure Drugs: Diuretics
763
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
763
01:30Heart Failure V: Medical Management
195
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
195
01:22Heart Failure Drugs: β-Blockers
724
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
724
01:29Heart Failure II: Pathophysiology
658
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
658
01:26Heart Failure Drugs: Inotropic Agents
1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K